Copy of Copy of invest in tb (5)

Research & Innovations

The End TB Strategy stipulates that major technological breakthroughs are needed by 2025, so that the rate at which TB incidence falls can be accelerated dramatically compared with historic levels. Delivering on these targets requires a multisectoral approach to developing and equitably diffusing the right medical innovations and strategies as a top priority. The main aim of investing in research and innovations on TB is to ensure providing simpler and quicker diagnostic services.

Invest in research and Innovative practices in the ever evolving and dynamic healthcare environment to identify effective and simpler solutions to achieve a TB Free India. 

  • Digital health solutions 
  • Cost-effective models for DR-TB management including contact tracing  
  • Support research in vaccine development for TB
  • Current innovations in corporate sector which have already been approved or are in the pilot stage.
  • Support Tele-consultation model for patients

Problem Statement

  • Strong health care systems are a prerequisite to achieving the goals and targets of the End TB Strategy. Owing to misaligned capabilities of healthcare systems like health workforce and drug supply, it becomes difficult to respond adequately to TB. There is a need for a strong body of knowledge, including from affected communities, on effective strategies for strengthening health and social care systems so that available technologies in TB deliver the maximum impact.
  • For the private sector, developing country markets are not sufficiently attractive to incentivize the full development of promising diagnostics, treatment and vaccine candidates. New models of partnerships, investment and incentives are needed to bridge this gap.
  • A large share of basic research is directed towards health priorities in developed markets; thus, key elements of basic science in TB biology, vaccines, diagnostic and drug discovery continues to be lacking unless specific dedicated funding for basic TB research is increased by funders of public health research.

Contact Us

Contact us to know more and understand how can you contribute towards the cause of TB-Free India by 2025.

Invest to Eliminate TB

Despite TB being a curable disease and free of cost treatment being provided by the Government, India continues to have the highest incidence of TB in the world along with highest TB mortality. Prime Minister Mr Narendra Modi committed to eliminate TB in India by 2025.  It is an ambitious target and there is a need for increased investments and partnerships by all sectors including the corporate sector to contribute to the goal of making India TB free. These partnerships will not only save lives but also help your brand gain the visibility it deserves as it cares for its people and communities,  and support interventions with measurable outcomes.

Delay in accurate diagnosis of tuberculosis in India is also due to untrained first line of contact, be it allopaths or alternative medicine.